Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Plasmacytoma × Drug Combinations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Plasmacytoma 1 Neoplasms 1 Homologous Recombination Deficient Solid Tumors 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Acrocephalosyndactylia 1

Interventions

pomalidomide 2 daratumumab 2 Dexamethasone 2 ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 cc-486 1 auricularum 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Gemcitabine 1 Drug Combinations 1 Calcium Dobesilate 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065308 2019-08-22

Dara_DCEP

Seoul National University Hospital

Phase 2 Unknown

Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡